To direct the Director of the Bureau of Prisons to provide medication assisted treatment for opioid addiction to certain women.
Key claim: HR9756 would direct the Bureau of Prisons to provide medication-assisted treatment for opioid addiction to certain women in federal custody.
Abstract
(HR9756 · 119th Congress) Latest action (2026-07-16): Referred to the House Committee on the Judiciary.
Why this matters
Medication-assisted treatment is the clinical standard of care for opioid use disorder, but access inside federal prisons has historically been inconsistent, with particular gaps for women who often enter custody with higher rates of opioid dependence and pregnancy-related treatment needs. A statutory directive would shift MAT from a discretionary BOP program to a required service for the defined population, affecting continuity of care, overdose risk on release, and equal-access claims across facilities.